Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
Status:
Withdrawn
Trial end date:
1999-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the abuse liability and reinforcing effects of
intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent
volunteers
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone